Results
Sun Pharma FY26 Revenue Growth 12% to ₹582 Billion
Sun Pharma reported FY26 revenue of ₹582.2 billion, a 12% YoY growth, with adjusted net profit at ₹124.0 billion.
The company is the 13th largest generics player in the US and maintains its position a
